Search Results - "Curzi, Paola"
-
1
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
Published in Cancers (16-09-2019)“…Myelodysplastic syndromes (MDS) are highly heterogeneous myeloid diseases, characterized by frequent genetic/chromosomal aberrations. Olaparib is a potent,…”
Get full text
Journal Article -
2
-
3
Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC
Published in Clinical chemistry (Baltimore, Md.) (01-11-2005)Get full text
Journal Article -
4
Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation
Published in Genes chromosomes & cancer (01-03-2009)“…The translocation t(16;21) involving RUNX1 (AML1) and resulting in the RUNX1‐CBFA2T3 fusion is a rare but recurrent abnormality mostly found in therapy‐related…”
Get full text
Journal Article -
5
Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation
Published in Annals of hematology (01-05-2007)“…Detection of genetic markers improves diagnostic refinement of chronic myeloproliferative disorders (CMDs) and is helpful in discriminating reactive conditions…”
Get full text
Journal Article -
6
Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia
Published in Cancer genetics and cytogenetics (01-12-2009)Get full text
Journal Article -
7
Molecular cytogenetic characterization of a complex rearrangement involving chromosomes 9 and 22 in a case of Ph-negative chronic myeloid leukemia
Published in Cancer genetics and cytogenetics (15-07-2002)“…The “golden path”, produced by the Human Genome Project effort, is composed of a collection of overlapping and fully sequenced BAC/PAC clones covering almost…”
Get full text
Journal Article